Cargando…
Additive Interaction Between the Renin-Angiotensin System and Lipid Metabolism for Cancer in Type 2 Diabetes
OBJECTIVE: Clinical and experimental studies suggest cross-talk between lipid metabolism and the renin-angiotensin system (RAS) in atherogenesis. The aim of this study was to explore interactions between these two systems in mediating cancer risk in type 2 diabetes. RESEARCH DESIGN AND METHODS: A pr...
Autores principales: | Yang, Xilin, Zhao, Hailu, Sui, Yi, Ma, Ronald C.W., So, Wing Yee, Ko, Gary T.C., Kong, Alice P.S., Ozaki, Risa, Yeung, Chun Yip, Xu, Gang, Tong, Peter C.Y., Chan, Juliana C.N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699870/ https://www.ncbi.nlm.nih.gov/pubmed/19401427 http://dx.doi.org/10.2337/db09-0105 |
Ejemplares similares
-
Validation of Methods to Control for Immortal Time Bias in a Pharmacoepidemiologic Analysis of Renin–Angiotensin System Inhibitors in Type 2 Diabetes
por: Yang, Xilin, et al.
Publicado: (2014) -
Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
por: Kong, Alice PS, et al.
Publicado: (2014) -
Additive Interaction of Hyperglycemia and Albuminuria on Risk of Ischemic Stroke in Type 2 Diabetes: Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2008) -
Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2010) -
Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2011)